Event for expert public only
Patient-derived Organoids in Cancer Research
Charité 3R cordially invites you to a lecture on patient-derived organoids presented by 2 outstanding experts in the field: Hugo Snippert, University Medical Center Utrecht, and Ulrich Keilholz, Charité, director of Charité Comprehensive Cancer Center, speaker of NCT Berlin
Hugo Snippert, University Medical Center Utrecht: Heterogeneity in tumors: a real-time and single-cell perspective
Internal speaker and moderation:
Ulrich Keilholz, Charité: Cancer Organoids to Move Clinical Cancer Research and Care
Hugo Snippert is a group leader at the Centre for Molecular Medicine at UMC Utrecht, an ERC starting grant holder and a member of the Oncode institute. His group “Functional heterogeneity in cancer” uses patient derived (cancer) organoids to study cell fate decisions. Hugo Snippert and his team are applying high-content microscopy to follow the trajectory of stem cells and to study the transition from benign to early-onset malignant tumors in intestine organoids. He established a protocol that integrates 3D live-cell imaging and whole-genome sequencing of patient derived organoids (PDOs) to reconstruct tumor evolution. He has an interest in the underlying mechanisms of colorectal cancer metastasizing to the liver.
Please take the opportunity to discuss with both speakers in a get-together with drinks and food from 4:30 pm on.
Hugo Snippert will be available for 1:1 meeting the day after, 12th of October, 9 – 12 a.m. If you are interested, please let us know: firstname.lastname@example.org.
Please register for the lecture until 4th of October.
Looking forward to interesting insights and a lively exchange!
Organizational and administrative matters
Hugo Snippert, University Medical Utrecht
Ulrich Keilholz, Charité, director of Charité Comprehensive Cancer Center, speaker of NCT Berlin
11.10.2023, 3 p.m. -4:30 p.m.
Campus Virchow Klinikum, Forum 4, Ground Floor, Pathology Lecture hall